$ARWR (-0.72%) | Sarepta Therapeutics Announces Global Licensing and Collaboration Agreement with Arrowhead Pharmaceuticals for Multiple Clinical and Preclinical siRNA Programs
- Markets
- Stocks
- Arrowhead Pharms
- Forum Discussion
Trending Securities
Top creators this week
Real-time data from LSX · Fundamentals & EOD data from FactSet
